Literature DB >> 29995484

Extending the Sunshine Act From Physicians to Patient Advocacy Organizations.

Genevieve P Kanter1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 29995484     DOI： 10.2105/AJPH.2018.304520

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  3 in total

1.  Lessons from Corporate Influence in the Opioid Epidemic: Toward a Norm of Separation.

Authors:  Jonathan H Marks
Journal:  J Bioeth Inq       Date:  2020-07-13       Impact factor: 1.352

2.  When patient advocacy organizations meet industry: a novel approach to dealing with financial conflicts of interest.

Authors:  Orna Ehrlich; Laura Wingate; Caren Heller; Inmaculada de Melo-Martin
Journal:  BMC Med Ethics       Date:  2019-12-17       Impact factor: 2.652

3.  Under-reported relationship: a comparative study of pharmaceutical industry and patient organisation payment disclosures in the UK (2012-2016).

Authors:  Piotr Ozieranski; Marcell Csanádi; Emily Rickard; Shai Mulinari
Journal:  BMJ Open       Date:  2020-09-19       Impact factor: 2.692
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.